NERVOUS SYSTEM DISEASES
Clinical trials for NERVOUS SYSTEM DISEASES explained in plain language.
Never miss a new study
Get alerted when new NERVOUS SYSTEM DISEASES trials appear
Sign up with your email to follow new studies for NERVOUS SYSTEM DISEASES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Sleep hormone fails to halt MS progression in early trial
Disease control TerminatedThis study tested whether adding melatonin to a standard MS drug (ocrelizumab) could slow disability in people with progressive multiple sclerosis. The trial was stopped early after enrolling only 25 participants. It aimed to measure changes in walking, arm function, and thinking…
Matched conditions: NERVOUS SYSTEM DISEASES
Phase: PHASE1, PHASE2 • Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla • Aim: Disease control
Last updated May 06, 2026 16:13 UTC
-
Alzheimer's drug safety study ends early
Disease control TerminatedThis study looked at the long-term safety and effects of a drug called XPro1595 in people with Alzheimer's disease who had already taken it in earlier studies. Only 11 people took part, and the study was stopped early. The main goal was to check for side effects and see if the dr…
Matched conditions: NERVOUS SYSTEM DISEASES
Phase: PHASE2 • Sponsor: Inmune Bio, Inc. • Aim: Disease control
Last updated May 01, 2026 15:58 UTC